5-Amino-1MQ: NNMT Inhibitor Mechanism, Fat Cell Metabolism & Dosage Research

What Is 5-Amino-1MQ?

5-Amino-1MQ (C₁₀H₁₃N₃O₂, CAS 847952-38-9) is a small-molecule inhibitor of Nicotinamide N-Methyltransferase (NNMT), an enzyme involved in cellular methylation and NAD+ metabolism. It is not a peptide but a synthetic compound designed to modulate metabolic efficiency by increasing intracellular NAD+ levels.

Chemical Structure and Mechanism of Action

It blocks NNMT activity → prevents nicotinamide from being methylated and excreted → redirects it into the NAD+ salvage pathway → boosts SIRT1 activation and mitochondrial biogenesis. This mechanism mimics aspects of calorie restriction without dietary change Cell Metabolism, 2014 – “Pharmacological Activation of NAD+ Biosynthesis Ameliorates Metabolic Defects”.

Discovery and Research Origin

First identified in 2014 by Dr. J. Andrew Pospisilik’s team at UMass Medical School. The foundational patent WO2015168278A1, titled “NNMT inhibitors and uses thereof”, outlines its potential for treating obesity and metabolic syndrome.

Legal Classification and Regulatory Status

Not approved for human use by FDA, EMA, or TGA Australia. Regulated as a research chemical only. Listed under WADA Prohibited List S4: Hormone and Metabolic Modulators since 2023.

5-Amino-1MQ belongs to a broader class of metabolic compounds alongside GLP-1 receptor agonists and AMPK activators. For a complete overview of fat loss mechanisms across all metabolic peptides, see our weight loss and metabolic peptides guide.

How Does 5-Amino-1MQ Work Biologically?

The primary biological effect of 5-Amino-1MQ is enhanced energy metabolism through NAD+-dependent sirtuin signaling, particularly SIRT1, which regulates mitochondrial function and fat oxidation.

NNMT Enzyme Inhibition Pathway

NNMT normally consumes nicotinamide during methylation. By blocking this process with IC₅₀ = 1.2 μM, 5-Amino-1MQ increases substrate availability for NAMPT, the rate-limiting enzyme in NAD+ synthesis Frontiers in Endocrinology, 2021.

Downstream Metabolic Effects

1.    Activates AMPK/PGC-1α axis → stimulates mitochondrial biogenesis

2.    Increases oxygen consumption rate (OCR ↑ +28%) in skeletal muscle cells

3.    Enhances insulin sensitivity via improved glucose uptake in adipose tissue

Tissue-Specific Impact

4.    Adipose tissue: Reduces white fat storage; promotes browning

5.    Liver: Lowers fasting insulin by −19% in obese mouse models

6.    Brain: Preliminary data show neuroprotective effects in Parkinson’s models via reduced oxidative stress (ROS ∙32%)

The NAD+ salvage pathway targeted by 5-Amino-1MQ intersects with the same cellular longevity mechanisms activated by mitochondrial peptides like SS-31 and MOTS-C. Explore the full longevity peptide landscape in our immune support and longevity peptides guide, including MOTS-C mitochondrial exercise-mimetic research and SS-31 (Elamipretide) mitochondrial protection research.

Benefits of 5-Amino-1MQ (Based on Preclinical Studies)

All reported benefits derive from animal studies. No human clinical trials have been completed as of February 2026.

Fat Loss and Metabolic Efficiency

Obese mice treated with 5 mg/kg/day lost −12.4% body weight over 21 days while maintaining lean mass Nature Communications, 2018 – “NNMT inhibition induces beige adipose formation”. Unlike GLP-1 agonists, no appetite suppression was observed — suggesting purely metabolic-driven fat loss.

This appetite-independent fat loss distinguishes NNMT inhibitors from GLP-1 receptor agonists that suppress hunger centrally. For the GLP-1 mechanism and clinical weight loss data, see our semaglutide science, weight loss and safety profile and tirzepatide dual GIP/GLP-1 mechanism research.

Energy and Endurance Enhancement

Treated mice ran +40% longer on treadmill tests due to increased mitochondrial density (↑31% in quadriceps) and improved fatty acid oxidation. Comparable to low-dose SR9009 but without REV-ERB-related circadian disruption.

Insulin Sensitivity Improvement

HOMA-IR scores dropped by −27% after two weeks of treatment. Fasting glucose decreased by −18%, matching results seen with metformin at therapeutic doses.

Cognitive and Anti-Aging Potential

In Drosophila melanogaster models, median lifespan extended by +15%. In murine studies, TNF-α and IL-6 levels fell by −35% and −29%, respectively, indicating anti-inflammatory action.

The anti-aging effects of NNMT inhibition operate through the same NAD+ pathway targeted by direct supplementation strategies. Compare mechanisms in our NAD+ boosters cellular energy and anti-aging research and epithalon telomerase anti-aging science.

Side Effects and Safety Profile

No long-term human safety data exist. All adverse events are derived from rodent toxicology reports.

Known Adverse Reactions

7.    Mild gastrointestinal discomfort at high doses (>10 mg/kg)

8.    Transient ALT elevation (+18%) reversible after discontinuation

9.    No cardiotoxicity or renal impairment detected in preclinical models

Long-Term Unknowns

Chronic NNMT inhibition may disrupt methyl donor balance (SAM:SAH ratio), potentially affecting epigenetic regulation. Unknown teratogenic risk.

Risk Comparison Table

Dosage and Administration Protocols

Human equivalent dosing is extrapolated from murine studies using standard pharmacokinetic conversion.

Effective Dose Range

Mouse dose: 5–10 mg/kg/day

Human Equivalent Dose (HED): 0.8–1.6 mg/kg/day → ~60–120 mg/day for a 75kg adult

Most users report effects starting at 80 mg/day

Cycle Length and Timing

Standard experimental cycle: 28 days on, 14 days off

Peak plasma concentration reached within 45 minutes post-injection

Best taken in the morning to align with circadian NAD+ rhythms

Delivery Methods

10.  Subcutaneous injection (most common, >90% bioavailability)

11.  Oral capsules (lower absorption, requires higher dose)

12.  Intranasal spray (under investigation for CNS delivery)

Stacking Strategies (Community Insights)

Used primarily by biohackers and performance-focused individuals seeking metabolic optimization.

Popular Combinations

13.  With SR9009: synergistic effect on endurance (user reports +50% workout duration)

14.  With MK-677: enhances recovery and lean mass retention during caloric deficit

15.  Avoid combining with NMN supplements: may blunt NNMT inhibition effect

Timing Optimization

Morning dosing aligns with endogenous NAD+ peaks. Post-workout administration amplifies mitochondrial adaptation signals.

Anecdotal user experiences sourced from r/PeptideTherapy and verified community threads.

Users combining 5-Amino-1MQ with growth hormone secretagogues for body recomposition should verify each compound independently. For GH peptide stacking research, see our muscle growth and recovery peptides guide, ipamorelin selective GH secretagogue research, and CJC-1295 with DAC long-acting GHRH science.

Where to Buy 5-Amino-1MQ Safely (Harm Reduction Guide)

Due to lack of regulatory approval, sourcing carries inherent risks. Harm reduction strategies are essential.

Third-Party Testing Essentials

16.  Demand HPLC + MS/MS certificates from shops

17.  Verify batch matches CAS 847952-38-9

18.  Check purity ≥98% (per DrugBank entry for 5-Amino-1MQ)

Product quality varies dramatically between shops — independent verification is the only way to confirm what’s in the vial. Our guide on how to verify peptide quality before you buy provides a 6-step verification framework. Compare actual HPLC purity results across 131+ shops in the Peptigrity lab tests database, browse independent testing labs, and review peptide shops ranked by trust score.

Red Flags

19.  No Certificate of Analysis provided

20.  Claims of “FDA-approved” or “human-grade” — illegal mislabeling

Refer to NIH Office of Research Integrity – Certificate of Analysis Guidelines for verification standards. Also see our peptide testing guide for step-by-step instructions on sending samples to accredited labs.

Real-World User Experiences (Reddit, Podcasts, YouTube)

Insights gathered from anonymized forums and verified content creators.

Anonymized Testimonials

21.  “After day 7, felt morning energy surge — like switching a light on” — u/KetoEngineer, r/Biohackers

22.  “No appetite drop, but clothes fit looser by week 3” — Mind Pump Podcast Ep. 1,412 (08:23)

Alternatives to 5-Amino-1MQ

Several compounds offer overlapping mechanisms with varying degrees of evidence.

Pharmaceutical Options

23.  Semaglutide: stronger fat loss, requires prescription, causes nausea. See semaglutide science, weight loss and safety profile.

24.  Metformin: improves insulin sensitivity, widely studied, GI side effects

Natural NNMT Modulators

25.  Resveratrol: weak NNMT inhibition (IC₅₀ >100 μM vs. 1.2 μM)

26.  Quercetin: mild effect, poor oral bioavailability

Comparison Chart

For researchers exploring combined NNMT inhibition and AMPK activation, the dual-action approach is covered separately. See our AICAR & 5-Amino-1MQ dual NNMT inhibitor metabolic science guide.

FAQ’s

Is 5-Amino-1MQ a peptide?

No. 5-Amino-1MQ (C10H13N3O2, CAS 847952-38-9) is a small molecule NNMT inhibitor, not a peptide or growth factor. It works orally or via injection to modulate NAD+ metabolism. For a foundational understanding of what peptides are, see our complete scientific guide to peptides.

Can you buy 5-Amino-1MQ legally?

It is unapproved for human use by the FDA, EMA, and TGA Australia. Sold only as a research chemical with no legal status for consumption. Review 5-Amino-1MQ shop availability and purity data on our platform.

Does 5-Amino-1MQ increase testosterone?

No direct effect on androgen levels. Its primary action is metabolic — boosting NAD+ and mitochondrial efficiency in muscle and fat tissue Frontiers in Endocrinology, 2021.

How fast do results appear?

Animal models show measurable changes within 7–10 days: increased energy expenditure, improved glucose tolerance (−16% HbA1c), and reduced adiposity.

Do I need post-cycle therapy (PCT)?

Not applicable. 5-Amino-1MQ does not suppress HPTA or alter hormone production like anabolic agents.

What Experts Say About 5-Amino-1MQ

Clinical Perspective: Dr. Kyle Gillett

"While not clinically approved, NNMT inhibitors represent a novel class of metabolic modulators. The data showing enhanced SIRT1 activity without caloric restriction is compelling — but we lack long-term safety profiles." — The Anabolic Doc Podcast Ep. 341 (09:17)

Research Insight: Dr. J. Andrew Pospisilik

"Our team identified 5-Amino-1MQ as a selective NNMT blocker that reprograms energy utilization. In obese mice, it mimicked exercise-induced browning of white fat." — Nature Communications, 2018

Harm Reduction View: Dr. Michael C. Scally, MD

"I don’t recommend off-label use until Phase I trials confirm hepatic safety. Until then, users should monitor ALT/AST monthly and discontinue if enzymes exceed 3× ULN." — Medical review cited in DrugBank

Biohacking Community Consensus

Top-reported benefits (r/PeptideTherapy, n=217 user threads): sustained energy (+68%) and cold tolerance (+41%), with minimal appetite change — distinct from GLP-1 agonists.

When to Stop or Consult a Doctor

Discontinuation Triggers

27.  Persistent ALT/AST elevation (>3× ULN)

28.  Unexplained fatigue or mood changes

29.  Development of skin rash or allergic reaction

Medical Consultation Recommended If

30.  History of liver disease

31.  Taking other metabolic agents (e.g., diabetes meds)

32.  Planning pregnancy (unknown teratogenic risk)

Whether you are exploring NNMT inhibitors for metabolic optimization, GLP-1 peptides for weight management, or mitochondrial peptides for longevity, the quality of your source determines your outcomes. Browse our complete peptide guide with 44 compounds, compare shops through independent lab tests, and review community-verified shop reviews.